Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Adaptimmune Therapeutics plc (ADAPY)
USD0.03
0.00 (-9.09%)
GB OTC Healthcare Biotechnology
Address
60 Jubilee Avenue OX14 4RX
Abingdon, GB
Abingdon, GB
CEO
Christopher James Hill
Website
adaptimmune.com
IPO
2015-05-06
CIK 1621227 ISIN US00653A1079
Also trades on
NASDAQ Global Select · ADAP (USD)
Other OTC · ADAPY (USD)
Description
Adaptimmune Therapeutics plc is a commercial-stage biopharmaceutical company specializing in innovative cell therapies for cancer patients, primarily operating in the United States and the United Kingdom. Its pipeline includes TECELRA (also known as famitresgene autoleucel or afami-cel), an autologous T-cell immunotherapy that employs genetically modified cells to treat adults with advanced, unresectable, or metastatic synovial sarcoma. The company is also advancing Lete-cel for synovial sarcoma and myxoid liposarcoma, and ADP-5701, currently in Phase 1 clinical trials for head and neck cancer. Additionally, Adaptimmune is developing T-cell therapies engineered to target PRAME (ADP-600) and CD70 (ADP-520). The firm engages in strategic collaborations, notably with Galapagos for a clinical proof-of-concept trial of uza-cel (ADP-5701) in head and neck cancer, leveraging Galapagos' decentralized manufacturing platform. Further partnerships include a licensing agreement with Noile-Immune Biotech, Inc. and a strategic alliance with the MD Anderson Cancer Center. Established in 2008, Adaptimmune Therapeutics plc is headquartered in Abingdon, United Kingdom.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
USD0.03
0.00 (-9.09%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
470.7K
Beta
1.76
Float Shares
263.34M
Free Float %
99.4%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -32.22% | -12.86% | -39.00% | -69.50% | -83.82% | -76.54% | -97.91% | -99.44% | -99.87% | -99.94% | -99.96% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Analyst Consensus (16 ratings, all time)
Buy
Price Targets & DCF
Current price
0.03
Low
1.00
+3,233.3%
Consensus
2.83
+9,333.3%
Median
3.00
+9,900.0%
High
4.00
+13,233.3%
Ratings Trend (MoM)
| Rating | 2026-02 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | -1 |
Price Target Summary
| Period | # Analysts | Avg Target |
|---|---|---|
| Last Month | — | — |
| Last Quarter | — | — |
| Last Year | — | — |
| All Time | 5 |
2.83
+9,333.3%
|
Quality scores
Altman Z-Score
-15.86
Distress
Piotroski F-Score
0 / 9
Weak
MOAT Score
0 / 10
No MOAT
Composite Rating
C
Overall Score
2 / 5
Medium
DCF Score
1 / 5
Low
ROE Score
5 / 5
High
ROA Score
1 / 5
Low
D/E Score
1 / 5
Low
P/E Score
1 / 5
Low
P/Book Score
1 / 5
Low
Operational MOAT
✗ Below peers
-
Revenue growth Biotechnology: +1.6%+195.3% ★ Q2'25: -89.3% (vs Q2'24)
-
EPS growth Biotechnology: +29.7%+50.9% ★ Q2'25: -144.4% (vs Q2'24)
-
FCF margin FCF growth · Biotechnology: +16.2%-55.8% Q2'25: -254.8% (vs Q2'24)
-
EBIT margin Biotechnology: +0.0%-35.9% Q2'25: -210.3% (vs Q2'24)
-
ROIC Biotechnology: -16.1%— Q2'25: +238.0% (vs Q2'24)
-
Share dilution Biotechnology: -3.4%+25.5% Q2'25: +1.6% (vs Q2'24)
-
Debt / EBITDA Net debt/EBITDA · Biotechnology: 0.16×-1.41× Q2'25: -0.46× (vs Q2'24)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 1 Rev. Ana. 1 EPS Ana. |
Dec 2027 1 Rev. Ana. 1 EPS Ana. |
Dec 2028 1 Rev. Ana. 1 EPS Ana. |
Dec 2029 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|
| Revenue |
178.03M
est: 182.68M (-2.5%)
|
27.44M
est.
|
20.70M
20.70M – 20.70M
-24.6% YoY
|
116.43M
116.43M – 116.43M
+462.5% YoY
|
182.16M
182.16M – 182.16M
+56.5% YoY
|
246.55M
246.55M – 246.55M
+35.3% YoY
|
| EBITDA |
-52.67M
est: -156.95M (+66.4%)
|
-23.58M
est.
|
-17.78M
-17.78M – -17.78M
+24.6% YoY
|
-100.03M
-100.03M – -100.03M
-462.5% YoY
|
-156.51M
-156.51M – -156.51M
-56.5% YoY
|
-211.83M
-211.83M – -211.83M
-35.3% YoY
|
| EBIT |
-63.89M
est: -159.26M (+59.9%)
|
-23.92M
est.
|
-18.05M
-18.05M – -18.05M
+24.6% YoY
|
-101.50M
-101.50M – -101.50M
-462.5% YoY
|
-158.80M
-158.80M – -158.80M
-56.5% YoY
|
-214.94M
-214.94M – -214.94M
-35.3% YoY
|
| Net Income |
-70.81M
est: -6.57M (-977.4%)
|
-20.18M
est.
|
-125.65M
-125.65M – -125.65M
-522.5% YoY
|
-17.66M
-17.66M – -17.66M
+85.9% YoY
|
-20.18M
-20.18M – -20.18M
-14.3% YoY
|
-20.18M
-20.18M – -20.18M
+0.0% YoY
|
| SGA |
81.31M
est: 908.75M (-91.1%)
|
136.51M
est.
|
102.97M
102.97M – 102.97M
-24.6% YoY
|
579.18M
579.18M – 579.18M
+462.5% YoY
|
906.15M
906.15M – 906.15M
+56.5% YoY
|
1.23B
1.23B – 1.23B
+35.3% YoY
|
| EPS |
-0.28
est: -0.03 (-974.9%)
|
-0.08
est.
|
-0.50
-0.50 – -0.50
-522.5% YoY
|
-0.07
-0.07 – -0.07
+85.9% YoY
|
-0.08
-0.08 – -0.08
-14.3% YoY
|
-0.08
-0.08 – -0.08
+0.0% YoY
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-28 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-27 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-26 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-22 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-21 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-20 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-19 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-18 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-15 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-14 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-13 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-12 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-11 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-06 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-05 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-04 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-01 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-30 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-29 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-28 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-27 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-24 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-23 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-22 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-21 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-20 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-17 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-16 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
-27.50M
OE per share TTM
-0.02
Owner's Yield
-1,707.31%
Maintenance CapEx ratio
—
Maint CapEx / Avg PPE
113.0%
Ownership Overview
Ownership breakdown
Ownership breakdown not available.
At a glance
Institutional holders
—
Total invested
—
Insider transactions (90d)
0
Beneficial owners (>5%)
0
Beneficial owners (>5%)
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional ownership trend
Institutional history not available.
Top institutional holders
Top holders not available.
ETF Ownership
Top ETFs holding this stock
This company is not held by any ETF in our universe.
Insider Activity
Insider Activity — Latest Quarter
Ratio by transactions
0.00
Bearish
Ratio by volume
0.00
Bearish
Buys
0
Sells
7
Shares acquired
—
Shares disposed
83.86M
Cash buys
—
Cash sales
7.00
Net activity
-83,855,538
Insider buys vs sells (history)
From
To
Recent insider transactions
From
To
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-09-10 | Hill Christopher James | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2025-09-02 | Wood Gavin | Officer | S-Sale | D | Ordinary Shares with a nominal value of GBP0.001 per share | 96,000 | 0.01 | 950.40 | 0 | D | ↗ |
| 2025-08-28 | Bertrand William C JR | Officer | S-Sale | D | Ordinary Shares with a nominal value of GBP0.001 per share | 207,000 | 0.01 | 2.1K | 986,352 | D | ↗ |
| 2025-08-18 | Behbahani Ali | Director | S-Sale | D | Ordinary Shares with a nominal value of 0.001 GBP per share | 14,671,794 | 0.01 | 176.1K | 0 | I | ↗ |
| 2025-08-15 | Behbahani Ali | Director | S-Sale | D | Ordinary Shares with a nominal value of 0.001 GBP per share | 4,828,206 | 0.01 | 53.1K | 14,671,794 | I | ↗ |
| 2025-07-30 | EcoR1 Capital, LLC | 10% Owner | S-Sale | D | Ordinary Shares | 27,433,338 | 0.10 | 2.80M | 100,371,882 | I | ↗ |
| 2025-07-29 | EcoR1 Capital, LLC | 10% Owner | S-Sale | D | Ordinary Shares | 2,687,460 | 0.10 | 272.0K | 127,805,220 | I | ↗ |
| 2025-07-28 | EcoR1 Capital, LLC | 10% Owner | S-Sale | D | Ordinary Shares | 33,931,740 | 0.11 | 3.82M | 130,492,680 | I | ↗ |
| 2025-02-20 | Rawcliffe Adrian | Director / Officer | A-Award | A | Option to purchase Ordinary Shares | 3,428,832 | 0.00 | 4.5K | 3,428,832 | D | ↗ |
| 2025-02-20 | Piccina Cintia | Officer | A-Award | A | Option to purchase Ordinary Shares | 1,612,032 | 0.10 | 161.2K | 1,612,032 | D | ↗ |
| 2025-02-20 | Norry Elliot | Officer | A-Award | A | Option to purchase Ordinary Shares | 1,074,696 | 0.00 | 1.4K | 1,074,696 | D | ↗ |
| 2025-02-20 | Lunger John | Officer | A-Award | A | Option to purchase Ordinary Shares | 1,074,696 | 0.00 | 1.4K | 1,074,696 | D | ↗ |
| 2025-02-20 | Brewer Joanna Elizabeth | Officer | A-Award | A | Option to purchase Ordinary Shares | 1,074,696 | 0.00 | 1.4K | 1,074,696 | D | ↗ |
| 2025-02-20 | Bertrand William C JR | Officer | A-Award | A | Option to purchase Ordinary Shares | 1,074,696 | 0.00 | 1.4K | 1,074,696 | D | ↗ |
| 2025-01-17 | Rawcliffe Adrian | Director / Officer | S-Sale | D | American Depositary Shares representing Ordinary Shares | 30,601 | 0.58 | 17.8K | 44,327 | D | ↗ |
| 2025-01-17 | Norry Elliot | Officer | S-Sale | D | American Depositary Shares representing Ordinary Shares | 5,584 | 0.58 | 3.2K | 7,510 | D | ↗ |
| 2025-01-17 | Lunger John | Officer | S-Sale | D | American Depositary Shares representing Ordinary Shares | 5,584 | 0.58 | 3.2K | 7,510 | D | ↗ |
| 2025-01-17 | Bertrand William C JR | Officer | S-Sale | D | American Depositary Shares representing Ordinary Shares | 5,584 | 0.58 | 3.2K | 7,510 | D | ↗ |
| 2025-01-15 | Rawcliffe Adrian | Director / Officer | S-Sale | D | American Depositary Shares representing Ordinary Shares | 29,096 | 0.57 | 16.7K | 41,582 | D | ↗ |
| 2025-01-15 | Piccina Cintia | Officer | S-Sale | D | American Depositary Shares representing Ordinary Shares | 12,991 | 0.57 | 7.5K | 18,421 | D | ↗ |
| 2025-01-15 | Norry Elliot | Officer | S-Sale | D | American Depositary Shares representing Ordinary Shares | 9,803 | 0.57 | 5.6K | 13,756 | D | ↗ |
| 2025-01-15 | Lunger John | Officer | S-Sale | D | American Depositary Shares representing Ordinary Shares | 9,803 | 0.57 | 5.6K | 13,756 | D | ↗ |
| 2025-01-15 | Bertrand William C JR | Officer | S-Sale | D | American Depositary Shares representing Ordinary Shares | 9,803 | 0.57 | 5.6K | 13,756 | D | ↗ |
| 2025-01-13 | Rawcliffe Adrian | Director / Officer | S-Sale | D | American Depositary Shares representing Ordinary Shares | 12,539 | 0.59 | 7.4K | 17,801 | D | ↗ |
| 2025-01-13 | Norry Elliot | Officer | S-Sale | D | American Depositary Shares representing Ordinary Shares | 4,268 | 0.59 | 2.5K | 5,845 | D | ↗ |
| 2025-01-13 | Lunger John | Officer | S-Sale | D | American Depositary Shares representing Ordinary Shares | 5,471 | 0.59 | 3.2K | 7,623 | D | ↗ |
| 2025-01-13 | Bertrand William C JR | Officer | S-Sale | D | American Depositary Shares representing Ordinary Shares | 4,268 | 0.59 | 2.5K | 5,845 | D | ↗ |
| 2024-07-01 | Menzel Garry E | Director | A-Award | A | Option to purchase Ordinary Shares | 1,121,604 | 0.16 | 179.5K | 1,121,604 | — | ↗ |
| 2024-07-01 | MOTT DAVID M | Director | A-Award | A | Option to purchase Ordinary Shares | 1,583,214 | 0.16 | 253.3K | 1,583,214 | — | ↗ |
| 2024-07-01 | Hege Kristen | Director | A-Award | A | Option to purchase Ordinary Shares | 660,000 | 0.16 | 105.6K | 660,000 | — | ↗ |
| 2024-07-01 | Hegde Priti | Director | A-Award | A | Option to purchase Ordinary Shares | 1,144,686 | 0.16 | 183.1K | 1,144,686 | — | ↗ |
| 2024-07-01 | Furey John | Director | A-Award | A | Option to purchase Ordinary Shares | 660,000 | 0.16 | 105.6K | 660,000 | — | ↗ |
| 2024-07-01 | Behbahani Ali | Director | A-Award | A | Option to purchase Ordinary Shares | 1,144,686 | 0.16 | 183.1K | 1,144,686 | — | ↗ |
| 2024-07-01 | Alleva Lawrence M | Director | A-Award | A | Option to purchase Ordinary Shares | 1,213,926 | 0.16 | 194.2K | 1,213,926 | — | ↗ |
| 2024-07-01 | Allen Andrew R | Director | A-Award | A | Option to purchase Ordinary Shares | 660,000 | 0.16 | 105.6K | 660,000 | — | ↗ |
| 2024-06-18 | Piccina Cintia | Officer | S-Sale | D | American Depositary Shares representing Ordinary Shares | 24,531 | 0.93 | 22.8K | 38,293 | — | ↗ |
| 2024-03-18 | Piccina Cintia | Officer | A-Award | A | Option to purchase Ordinary Shares | 5,088,864 | 0.25 | 1.27M | 5,088,864 | — | ↗ |
| 2024-03-08 | EcoR1 Capital, LLC | 10% Owner | — | I | Ordinary Shares | 0 | 0.00 | — | 164,424,420 | — | ↗ |
| 2024-01-17 | Rawcliffe Adrian | Director / Officer | S-Sale | D | American Depositary Shares representing Ordinary Shares | 30,080 | 0.67 | 20.2K | 44,848 | — | ↗ |
| 2024-01-17 | Norry Elliot | Officer | S-Sale | D | American Depositary Shares representing Ordinary Shares | 5,309 | 0.67 | 3.6K | 7,785 | — | ↗ |
| 2024-01-17 | Lunger John | Officer | S-Sale | D | American Depositary Shares representing Ordinary Shares | 12,805 | 0.67 | 8.6K | 19,015 | — | ↗ |
| 2024-01-17 | Bertrand William C JR | Officer | S-Sale | D | American Depositary Shares representing Ordinary Shares | 5,309 | 0.67 | 3.6K | 7,785 | — | ↗ |
| 2024-01-16 | Rawcliffe Adrian | Director / Officer | S-Sale | D | American Depositary Shares representing Ordinary Shares | 9,304 | 0.79 | 7.4K | 14,104 | — | ↗ |
| 2024-01-16 | Norry Elliot | Officer | S-Sale | D | American Depositary Shares representing Ordinary Shares | 2,287 | 0.79 | 1.8K | 3,363 | — | ↗ |
| 2024-01-16 | Lunger John | Officer | S-Sale | D | American Depositary Shares representing Ordinary Shares | 4,681 | 0.79 | 3.7K | 7,023 | — | ↗ |
| 2024-01-16 | Bertrand William C JR | Officer | S-Sale | D | American Depositary Shares representing Ordinary Shares | 4,681 | 0.79 | 3.7K | 7,023 | — | ↗ |
| 2024-01-15 | Wood Gavin | Officer | A-Award | A | Option to purchase Ordinary Shares | 565,416 | 0.00 | 735.04 | 565,416 | — | ↗ |
| 2024-01-15 | TAYTON-MARTIN HELEN KATRINA | Officer | A-Award | A | Option to purchase Ordinary Shares | 2,544,432 | 0.14 | 356.2K | 2,544,432 | — | ↗ |
| 2024-01-15 | Rawcliffe Adrian | Director / Officer | A-Award | A | Option to purchase Ordinary Shares | 1,696,272 | 0.00 | 2.2K | 1,696,272 | — | ↗ |
| 2024-01-15 | Norry Elliot | Officer | A-Award | A | Option to purchase Ordinary Shares | 565,416 | 0.00 | 735.04 | 565,416 | — | ↗ |
| 2024-01-15 | Lunger John | Officer | A-Award | A | Option to purchase Ordinary Shares | 565,416 | 0.00 | 735.04 | 565,416 | — | ↗ |
| 2024-01-15 | Hege Kristen | Director | A-Award | A | Option to purchase Ordinary Shares | 81,906 | 0.14 | 11.5K | 81,906 | — | ↗ |
| 2024-01-15 | Brewer Joanna Elizabeth | Officer | A-Award | A | Option to purchase Ordinary Shares | 565,416 | 0.00 | 735.04 | 565,416 | — | ↗ |
| 2024-01-15 | Bertrand William C JR | Officer | A-Award | A | Option to purchase Ordinary Shares | 565,416 | 0.00 | 735.04 | 565,416 | — | ↗ |
| 2024-01-15 | Behbahani Ali | Director | A-Award | A | Option to purchase Ordinary Shares | 40,950 | 0.14 | 5.7K | 40,950 | — | ↗ |
| 2024-01-12 | Rawcliffe Adrian | Director / Officer | S-Sale | D | American Depositary Shares representing Ordinary Shares | 17,257 | 0.85 | 14.7K | 26,388 | — | ↗ |
| 2024-01-12 | Norry Elliot | Officer | S-Sale | D | American Depositary Shares representing Ordinary Shares | 7,799 | 0.85 | 6.7K | 11,841 | — | ↗ |
| 2024-01-12 | Lunger John | Officer | S-Sale | D | American Depositary Shares representing Ordinary Shares | 5,220 | 0.85 | 4.5K | 7,874 | — | ↗ |
| 2024-01-12 | Bertrand William C JR | Officer | S-Sale | D | American Depositary Shares representing Ordinary Shares | 5,220 | 0.85 | 4.5K | 7,874 | — | ↗ |
| 2024-01-11 | Rawcliffe Adrian | Director / Officer | S-Sale | D | American Depositary Shares representing Ordinary Shares | 11,945 | 0.84 | 10.0K | 18,395 | — | ↗ |
| 2024-01-11 | Norry Elliot | Officer | S-Sale | D | American Depositary Shares representing Ordinary Shares | 4,009 | 0.84 | 3.4K | 6,104 | — | ↗ |
| 2024-01-11 | Lunger John | Officer | S-Sale | D | American Depositary Shares representing Ordinary Shares | 4,009 | 0.84 | 3.4K | 6,104 | — | ↗ |
| 2024-01-11 | Bertrand William C JR | Officer | S-Sale | D | American Depositary Shares representing Ordinary Shares | 4,009 | 0.84 | 3.4K | 6,104 | — | ↗ |
| 2023-11-01 | Hege Kristen | Director | — | D | Option to purchase Ordinary Shares | 1,000,000 | 0.09 | 90.0K | 0 | — | ↗ |
| 2023-09-01 | Rawcliffe Adrian | Director / Officer | S-Sale | D | American Depositary Shares representing Ordinary Shares | 2,403 | 0.78 | 1.9K | 3,449 | — | ↗ |
| 2023-08-01 | Lunger John | Officer | S-Sale | D | American Depositary Shares representing Ordinary Shares | 3,096 | 0.91 | 2.8K | 4,718 | — | ↗ |
| 2023-07-10 | Menzel Garry E | Director | S-Sale | D | American Depositary Shares representing Ordinary Shares | 47,702 | 0.91 | 43.4K | 75,056 | — | ↗ |
| 2023-07-05 | Menzel Garry E | Director | A-Award | A | Option to Purchase Ordinary Shares | 359,700 | 0.65 | 233.8K | 359,700 | — | ↗ |
| 2023-07-05 | Hegde Priti | Director | A-Award | A | Option to Purchase Ordinary Shares | 109,746 | 0.57 | 62.6K | 109,746 | — | ↗ |
| 2023-07-05 | Allen Andrew R | Director | A-Award | A | Option to Purchase Ordinary Shares | 56,868 | 1.78 | 101.2K | 56,868 | — | ↗ |
| 2023-07-03 | Sigal Charles Elliott | Director | A-Award | A | Option to purchase Ordinary Shares | 933,317 | 0.16 | 149.3K | 933,317 | — | ↗ |
| 2023-07-03 | Menzel Garry E | Director | A-Award | A | Option to purchase Ordinary Shares | 981,463 | 0.16 | 157.0K | 981,463 | — | ↗ |
| 2023-07-03 | MOTT DAVID M | Director | A-Award | A | Option to purchase Ordinary Shares | 1,462,927 | 0.16 | 234.1K | 1,462,927 | — | ↗ |
| 2023-07-03 | Hegde Priti | Director | A-Award | A | Option to purchase Ordinary Shares | 500,000 | 0.16 | 80.0K | 500,000 | — | ↗ |
| 2023-07-03 | Furey John | Director | A-Award | A | Option to purchase Ordinary Shares | 500,000 | 0.16 | 80.0K | 500,000 | — | ↗ |
| 2023-07-03 | Behbahani Ali | Director | A-Award | A | Option to purchase Ordinary Shares | 933,317 | 0.16 | 149.3K | 933,317 | — | ↗ |
| 2023-07-03 | Alleva Lawrence M | Director | A-Award | A | Option to purchase Ordinary Shares | 1,077,756 | 0.16 | 172.4K | 1,077,756 | — | ↗ |
| 2023-07-03 | Allen Andrew R | Director | A-Award | A | Option to purchase Ordinary Shares | 500,000 | 0.16 | 80.0K | 500,000 | — | ↗ |
| 2023-06-27 | Rawcliffe Adrian | Director / Officer | S-Sale | D | American Depositary Shares representing Ordinary Shares | 2,333 | 0.92 | 2.1K | 3,519 | — | ↗ |
| 2023-06-01 | Menzel Garry E | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2023-06-01 | Hegde Priti | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2023-06-01 | Allen Andrew R | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2023-01-31 | Piccina Cintia | Officer | S-Sale | D | American Depositary Shares representing Ordinary Shares | 11,890 | 1.87 | 22.2K | 19,535 | — | ↗ |
| 2023-01-17 | Wood Gavin | Officer | A-Award | A | Option to purchase Ordinary Shares | 193,728 | 0.00 | — | 193,728 | — | ↗ |
| 2023-01-17 | TAYTON-MARTIN HELEN KATRINA | Officer | A-Award | A | Option to purchase Ordinary Shares | 1,407,072 | 0.00 | — | 1,407,072 | — | ↗ |
| 2023-01-17 | Rawcliffe Adrian | Officer | A-Award | A | Option to purchase Ordinary Shares | 1,798,272 | 0.00 | — | 1,798,272 | — | ↗ |
| 2023-01-17 | Piccina Cintia | Officer | A-Award | A | Option to purchase Ordinary Shares | 181,560 | 0.00 | — | 181,560 | — | ↗ |
| 2023-01-17 | Norry Elliot | Officer | A-Award | A | Option to purchase Ordinary Shares | 193,344 | 0.00 | — | 193,344 | — | ↗ |
| 2023-01-17 | Lunger John | Officer | S-Sale | D | American Depositary Shares representing Ordinary Shares | 4,440 | 1.86 | 8.2K | 7,264 | — | ↗ |
| 2023-01-17 | Brewer Joanna Elizabeth | Officer | A-Award | A | Option to purchase Ordinary Shares | 135,480 | 0.00 | — | 135,480 | — | ↗ |
| 2023-01-17 | Bertrand William C JR | Officer | A-Award | A | Option to purchase Ordinary Shares | 314,256 | 0.00 | — | 314,256 | — | ↗ |
| 2023-01-12 | Rawcliffe Adrian | Officer | S-Sale | D | American Depositary Shares representing Ordinary Shares | 18,763 | 1.71 | 32.0K | 24,882 | — | ↗ |
| 2023-01-12 | Norry Elliot | Officer | S-Sale | D | American Depositary Shares representing Ordinary Shares | 7,449 | 1.71 | 12.7K | 12,191 | — | ↗ |
| 2023-01-12 | Lunger John | Officer | S-Sale | D | American Depositary Shares representing Ordinary Shares | 4,973 | 1.71 | 8.5K | 8,121 | — | ↗ |
| 2023-01-12 | Bertrand William C JR | Officer | S-Sale | D | American Depositary Shares representing Ordinary Shares | 4,973 | 1.71 | 8.5K | 8,121 | — | ↗ |
| 2023-01-11 | Rawcliffe Adrian | Officer | S-Sale | D | American Depositary Shares representing Ordinary Shares | 13,042 | 1.75 | 22.8K | 17,298 | — | ↗ |
| 2023-01-11 | Norry Elliot | Officer | S-Sale | D | American Depositary Shares representing Ordinary Shares | 3,843 | 1.75 | 6.7K | 6,270 | — | ↗ |
| 2023-01-11 | Lunger John | Officer | S-Sale | D | American Depositary Shares representing Ordinary Shares | 3,843 | 1.75 | 6.7K | 6,270 | — | ↗ |
| 2023-01-11 | Bertrand William C JR | Officer | S-Sale | D | American Depositary Shares representing Ordinary Shares | 3,843 | 1.75 | 6.7K | 6,270 | — | ↗ |
| 2023-01-04 | Rawcliffe Adrian | Officer | S-Sale | D | American Depositary Shares representing Ordinary Shares | 5,073 | 1.69 | 8.6K | 6,631 | — | ↗ |
| 2023-01-04 | Norry Elliot | Officer | S-Sale | D | American Depositary Shares representing Ordinary Shares | 876 | 1.69 | 1.5K | 1,361 | — | ↗ |
| 2023-01-04 | Lunger John | Officer | S-Sale | D | American Depositary Shares representing Ordinary Shares | 1,100 | 1.69 | 1.9K | 1,725 | — | ↗ |
| 2023-01-04 | Bertrand William C JR | Officer | S-Sale | D | American Depositary Shares representing Ordinary Shares | 3,584 | 1.69 | 6.1K | 5,781 | — | ↗ |
| 2022-09-01 | Rawcliffe Adrian | Officer | S-Sale | D | American Depositary Shares representing Ordinary Shares | 2,536 | 1.97 | 5.0K | 3,316 | — | ↗ |
| 2022-08-01 | Piccina Cintia | Officer | S-Sale | D | American Depositary Shares representing Ordinary Shares | 21,040 | 1.77 | 37.3K | 34,824 | — | ↗ |
| 2022-08-01 | Lunger John | Officer | S-Sale | D | American Depositary Shares representing Ordinary Shares | 2,983 | 1.77 | 5.3K | 4,829 | — | ↗ |
| 2022-07-05 | Lunger John | Officer | S-Sale | D | American Depositary Shares representing Ordinary Shares | 1,973 | 1.68 | 3.3K | 3,104 | — | ↗ |
| 2022-07-01 | Zaks Tal Zvi | Director | A-Award | A | Option to purchase Ordinary Shares | 500,000 | 0.28 | 140.0K | 500,000 | — | ↗ |
| 2022-07-01 | Sigal Charles Elliott | Director | A-Award | A | Option to purchase Ordinary Shares | 737,050 | 0.00 | — | 737,050 | — | ↗ |
| 2022-07-01 | Noble James | Director | A-Award | A | Option to purchase Ordinary Shares | 710,711 | 0.00 | — | 710,711 | — | ↗ |
| 2022-07-01 | MOTT DAVID M | Director | A-Award | A | Option to purchase Ordinary Shares | 1,000,439 | 0.28 | 280.1K | 1,000,439 | — | ↗ |
| 2022-07-01 | Furey John | Director | A-Award | A | Option to purchase Ordinary Shares | 500,000 | 0.28 | 140.0K | 500,000 | — | ↗ |
| 2022-07-01 | Duncan Barbara Gayle | Director | A-Award | A | Option to purchase Ordinary Shares | 500,000 | 0.00 | — | 500,000 | — | ↗ |
| 2022-07-01 | Behbahani Ali | Director | A-Award | A | Option to purchase Ordinary Shares | 737,050 | 0.00 | — | 737,050 | — | ↗ |
| 2022-07-01 | Alleva Lawrence M | Director | A-Award | A | Option to purchase Ordinary Shares | 816,067 | 0.00 | — | 816,067 | — | ↗ |
| 2022-06-27 | Rawcliffe Adrian | Officer | S-Sale | D | American Depositary Shares representing Ordinary Shares | 2,562 | 1.63 | 4.2K | 3,290 | — | ↗ |
| 2022-05-20 | Wood Gavin | Officer | P-Purchase | A | Ordinary Shares with a nominal value of GBP0.001 per share | 39,000 | 0.29 | 11.3K | 96,000 | — | ↗ |
| 2022-05-04 | Brewer Joanna Elizabeth | Officer | A-Award | A | Option to purchase Ordinary Shares | 333,792 | 0.00 | — | 333,792 | — | ↗ |
| 2022-01-31 | Piccina Cintia | Officer | A-Award | A | Option to purchase Ordinary Shares | 3,376,992 | 0.45 | 1.52M | 3,376,992 | — | ↗ |
| 2022-01-18 | Rawcliffe Adrian | Director / Officer | S-Sale | D | American Depositary Shares representing Ordinary Shares | 11,096 | 3.19 | 35.4K | 12,312 | — | ↗ |
| 2022-01-18 | Norry Elliot | Officer | S-Sale | D | American Depositary Shares representing Ordinary Shares | 2,121 | 3.19 | 6.8K | 3,529 | — | ↗ |
| 2022-01-18 | Lunger John | Officer | S-Sale | D | American Depositary Shares representing Ordinary Shares | 4,368 | 3.19 | 13.9K | 7,336 | — | ↗ |
| 2022-01-18 | Bertrand William C JR | Officer | S-Sale | D | American Depositary Shares representing Ordinary Shares | 4,368 | 3.19 | 13.9K | 7,336 | — | ↗ |
| 2022-01-12 | Wood Gavin | Officer | A-Award | A | Option to purchase Ordinary Shares | 314,256 | 0.00 | 439.96 | 314,256 | — | ↗ |
| 2022-01-12 | TAYTON-MARTIN HELEN KATRINA | Officer | A-Award | A | Option to purchase Ordinary Shares | 314,256 | 0.00 | 439.96 | 314,256 | — | ↗ |
| 2022-01-12 | Rawcliffe Adrian | Director / Officer | A-Award | A | Option to purchase Ordinary Shares | 4,690,224 | 0.60 | 2.81M | 4,690,224 | — | ↗ |
| 2022-01-12 | Norry Elliot | Officer | S-Sale | D | American Depositary Shares representing Ordinary Shares | 854 | 3.54 | 3.0K | 1,383 | — | ↗ |
| 2022-01-12 | Lunger John | Officer | S-Sale | D | American Depositary Shares representing Ordinary Shares | 1,076 | 3.54 | 3.8K | 1,749 | — | ↗ |
| 2022-01-12 | Bertrand William C JR | Officer | S-Sale | D | American Depositary Shares representing Ordinary Shares | 2,248 | 3.54 | 8.0K | 3,754 | — | ↗ |
| 2022-01-11 | Rawcliffe Adrian | Director / Officer | S-Sale | D | American Depositary Shares representing Ordinary Shares | 14,362 | 3.56 | 51.1K | 15,978 | — | ↗ |
| 2022-01-11 | Norry Elliot | Officer | S-Sale | D | American Depositary Shares representing Ordinary Shares | 3,770 | 3.56 | 13.4K | 6,343 | — | ↗ |
| 2022-01-11 | Lunger John | Officer | S-Sale | D | American Depositary Shares representing Ordinary Shares | 3,770 | 3.56 | 13.4K | 6,343 | — | ↗ |
| 2022-01-11 | Bertrand William C JR | Officer | S-Sale | D | American Depositary Shares representing Ordinary Shares | 3,770 | 3.56 | 13.4K | 6,343 | — | ↗ |
| 2022-01-04 | Rawcliffe Adrian | Director / Officer | S-Sale | D | American Depositary Shares representing Ordinary Shares | 5,532 | 4.06 | 22.5K | 6,172 | — | ↗ |
| 2022-01-04 | Norry Elliot | Officer | S-Sale | D | American Depositary Shares representing Ordinary Shares | 849 | 4.06 | 3.5K | 1,388 | — | ↗ |
| 2022-01-04 | Lunger John | Officer | S-Sale | D | American Depositary Shares representing Ordinary Shares | 1,070 | 4.06 | 4.3K | 1,755 | — | ↗ |
| 2022-01-04 | Bertrand William C JR | Officer | S-Sale | D | American Depositary Shares representing Ordinary Shares | 3,490 | 4.06 | 14.2K | 5,873 | — | ↗ |
| 2021-09-01 | Rawcliffe Adrian | Director / Officer | S-Sale | D | American Depositary Shares representing Ordinary Shares | 2,782 | 5.20 | 14.5K | 3,070 | — | ↗ |
| 2021-08-02 | Lunger John | Officer | S-Sale | D | American Depositary Shares representing Ordinary Shares | 2,939 | 3.58 | 10.5K | 4,873 | — | ↗ |
| 2021-07-02 | Lunger John | Officer | S-Sale | D | American Depositary Shares representing Ordinary Shares | 1,907 | 4.26 | 8.1K | 3,170 | — | ↗ |
| 2021-07-02 | Bertrand William C JR | Officer | S-Sale | D | American Depositary Shares representing Ordinary Shares | 4,375 | 4.26 | 18.7K | 7,329 | — | ↗ |
| 2021-07-01 | Zaks Tal Zvi | Director | A-Award | A | Option to purchase Ordinary Shares | 379,788 | 0.71 | 269.6K | 379,788 | — | ↗ |
| 2021-07-01 | Sigal Charles Elliott | Director | A-Award | A | Option to purchase Ordinary Shares | 474,385 | 0.71 | 336.8K | 474,385 | — | ↗ |
| 2021-07-01 | Noble James | Director | A-Award | A | Option to purchase Ordinary Shares | 379,788 | 0.71 | 269.6K | 379,788 | — | ↗ |
| 2021-07-01 | MOTT DAVID M | Director | A-Award | A | Option to purchase Ordinary Shares | 579,494 | 0.71 | 411.4K | 579,494 | — | ↗ |
| 2021-07-01 | Furey John | Director | A-Award | A | Option to purchase Ordinary Shares | 379,788 | 0.71 | 269.6K | 379,788 | — | ↗ |
| 2021-07-01 | Duncan Barbara Gayle | Director | A-Award | A | Option to purchase Ordinary Shares | 379,788 | 0.71 | 269.6K | 379,788 | — | ↗ |
| 2021-07-01 | Behbahani Ali | Director | A-Award | A | Option to purchase Ordinary Shares | 474,385 | 0.71 | 336.8K | 474,385 | — | ↗ |
| 2021-07-01 | Alleva Lawrence M | Director | A-Award | A | Option to purchase Ordinary Shares | 505,918 | 0.71 | 359.2K | 505,918 | — | ↗ |
| 2021-06-28 | Rawcliffe Adrian | Director / Officer | S-Sale | D | American Depositary Shares representing Ordinary Shares | 2,794 | 4.37 | 12.2K | 3,058 | — | ↗ |
| 2021-06-01 | Alleva Lawrence M | Director | P-Purchase | A | Ordinary Shares with a nominal value of GBP0.001 per share | 12,600 | 0.79 | 10.0K | 12,600 | — | ↗ |
| 2021-03-03 | TAYTON-MARTIN HELEN KATRINA | Officer | M-Exempt | A | Ordinary Shares with a nominal value of GBP0.001 per share | 1,785,000 | 0.16 | 280.2K | 1,800,000 | — | ↗ |
| 2021-01-19 | Rawcliffe Adrian | Director / Officer | S-Sale | D | American Depositary Shares representing Ordinary Shares | 9,879 | 5.67 | 56.0K | 13,529 | — | ↗ |
| 2021-01-19 | Norry Elliot | Officer | S-Sale | D | American Depositary Shares representing Ordinary Shares | 2,111 | 5.67 | 12.0K | 3,539 | — | ↗ |
| 2021-01-19 | Lunger John | Officer | S-Sale | D | American Depositary Shares representing Ordinary Shares | 4,358 | 5.67 | 24.7K | 7,346 | — | ↗ |
| 2021-01-12 | Rawcliffe Adrian | Director / Officer | S-Sale | D | American Depositary Shares representing Ordinary Shares | 2,707 | 6.15 | 16.7K | 3,695 | — | ↗ |
| 2021-01-12 | Norry Elliot | Officer | S-Sale | D | American Depositary Shares representing Ordinary Shares | 841 | 6.15 | 5.2K | 1,396 | — | ↗ |
| 2021-01-12 | Lunger John | Officer | S-Sale | D | American Depositary Shares representing Ordinary Shares | 1,058 | 6.15 | 6.5K | 1,767 | — | ↗ |
| 2021-01-12 | Bertrand William C JR | Officer | S-Sale | D | American Depositary Shares representing Ordinary Shares | 2,234 | 6.15 | 13.7K | 3,768 | — | ↗ |
| 2021-01-11 | Wood Gavin | Officer | A-Award | A | Option to purchase Ordinary Shares | 242,712 | 0.00 | 339.80 | 242,712 | — | ↗ |
| 2021-01-11 | TAYTON-MARTIN HELEN KATRINA | Officer | A-Award | A | Option to purchase Ordinary Shares | 1,086,816 | 1.03 | 1.12M | 1,086,816 | — | ↗ |
| 2021-01-11 | Rawcliffe Adrian | Director / Officer | A-Award | A | Option to purchase Ordinary Shares | 3,260,400 | 1.03 | 3.36M | 3,260,400 | — | ↗ |
| 2021-01-11 | Norry Elliot | Officer | A-Award | A | Option to purchase Ordinary Shares | 1,086,816 | 1.03 | 1.12M | 1,086,816 | — | ↗ |
| 2021-01-11 | Lunger John | Officer | A-Award | A | Option to purchase Ordinary Shares | 242,712 | 0.00 | 339.80 | 242,712 | — | ↗ |
| 2021-01-11 | Bertrand William C JR | Officer | A-Award | A | Option to purchase Ordinary Shares | 1,086,816 | 1.03 | 1.12M | 1,086,816 | — | ↗ |
| 2021-01-04 | Rawcliffe Adrian | Director / Officer | S-Sale | D | American Depositary Shares representing Ordinary Shares | 4,967 | 5.33 | 26.5K | 6,737 | — | ↗ |
| 2021-01-04 | Norry Elliot | Officer | S-Sale | D | American Depositary Shares representing Ordinary Shares | 845 | 5.33 | 4.5K | 1,392 | — | ↗ |
| 2021-01-04 | Lunger John | Officer | S-Sale | D | American Depositary Shares representing Ordinary Shares | 1,065 | 5.33 | 5.7K | 1,760 | — | ↗ |
| 2021-01-04 | Bertrand William C JR | Officer | S-Sale | D | American Depositary Shares representing Ordinary Shares | 3,499 | 5.33 | 18.6K | 5,864 | — | ↗ |
| 2020-12-14 | Wood Gavin | Officer | P-Purchase | A | Ordinary Shares with a nominal value of GBP0.001 per share | 24,000 | 0.69 | 16.6K | 57,000 | — | ↗ |
| 2020-12-14 | Bertrand William C JR | Officer | P-Purchase | A | Ordinary Shares with a nominal value of GBP0.001 per share | 207,000 | 0.69 | 143.8K | 284,808 | — | ↗ |
| 2020-09-01 | Rawcliffe Adrian | Director / Officer | S-Sale | D | American Depositary Shares representing Ordinary Shares | 2,776 | 8.51 | 23.6K | 3,076 | — | ↗ |
| 2020-08-03 | TAYTON-MARTIN HELEN KATRINA | Officer | S-Sale | D | American Depositary Shares | 200,000 | 8.74 | 1.75M | 0 | — | ↗ |
| 2020-08-03 | Rawcliffe Adrian | Director / Officer | S-Sale | D | American Depositary Shares representing Ordinary Shares | 2,788 | 9.25 | 25.8K | 3,064 | — | ↗ |
| 2020-08-03 | Lunger John | Officer | S-Sale | D | American Depositary Shares representing Ordinary Shares | 4,823 | 9.25 | 44.6K | 8,066 | — | ↗ |
| 2020-07-01 | Zaks Tal Zvi | Director | A-Award | A | Option to purchase Ordinary Shares | 144,000 | 1.67 | 240.5K | 144,000 | — | ↗ |
| 2020-07-01 | Sigal Charles Elliott | Director | A-Award | A | Option to purchase Ordinary Shares | 184,258 | 1.67 | 307.7K | 184,258 | — | ↗ |
| 2020-07-01 | Noble James | Director | A-Award | A | Option to purchase Ordinary Shares | 179,785 | 1.67 | 300.2K | 179,785 | — | ↗ |
| 2020-07-01 | MOTT DAVID M | Director | A-Award | A | Option to purchase Ordinary Shares | 226,753 | 1.67 | 378.7K | 226,753 | — | ↗ |
| 2020-07-01 | Furey John | Director | A-Award | A | Option to purchase Ordinary Shares | 196,186 | 1.67 | 327.6K | 196,186 | — | ↗ |
| 2020-07-01 | Duncan Barbara Gayle | Director | A-Award | A | Option to purchase Ordinary Shares | 144,000 | 1.67 | 240.5K | 144,000 | — | ↗ |
| 2020-07-01 | Behbahani Ali | Director | A-Award | A | Option to purchase Ordinary Shares | 184,258 | 1.67 | 307.7K | 184,258 | — | ↗ |
| 2020-07-01 | Alleva Lawrence M | Director | A-Award | A | Option to purchase Ordinary Shares | 197,678 | 1.67 | 330.1K | 197,678 | — | ↗ |
| 2020-06-29 | Wood Gavin | Officer | P-Purchase | A | Ordinary Shares with a nominal value of GBP0.001 per share | 33,000 | 1.62 | 53.5K | 33,000 | — | ↗ |
| 2020-06-09 | Alleva Lawrence M | Director | P-Purchase | A | Ordinary Shares with a nominal value of GBP0.001 per share | 12,900 | 1.89 | 24.4K | 12,900 | — | ↗ |
| 2020-05-29 | Noble James | Director | S-Sale | D | American Depositary Shares | 500,000 | 9.33 | 4.67M | 0 | — | ↗ |
| 2020-04-01 | Wood Gavin | Officer | A-Award | A | Option to purchase Ordinary Shares | 2,500,000 | 0.45 | 1.13M | 2,500,000 | — | ↗ |
| 2020-04-01 | Noble James | Director | A-Award | A | Option to purchase Ordinary Shares | 31,000 | 0.45 | 14.0K | 31,000 | — | ↗ |
| 2020-01-24 | Sonsini Peter W. | 10% Owner | P-Purchase | A | Ordinary Shares with a nominal value of 0.001 GBP per share | 7,500,000 | 0.67 | 5.00M | 19,500,000 | — | ↗ |
| 2020-01-24 | SANDELL SCOTT D | 10% Owner | P-Purchase | A | Ordinary Shares with a nominal value of 0.001 GBP per share | 7,500,000 | 0.67 | 5.00M | 19,500,000 | — | ↗ |
| 2020-01-24 | MOTT DAVID M | Director / 10% Owner | P-Purchase | A | Ordinary Shares with a nominal value of 0.001 GBP per share | 7,500,000 | 0.67 | 5.00M | 19,500,000 | — | ↗ |
| 2020-01-24 | Florence Anthony A. Jr. | 10% Owner | P-Purchase | A | Ordinary Shares with a nominal value of 0.001 GBP per share | 7,500,000 | 0.67 | 5.00M | 19,500,000 | — | ↗ |
| 2020-01-24 | Behbahani Ali | Director | P-Purchase | A | Ordinary Shares with a nominal value of 0.001 GBP per share | 7,500,000 | 0.67 | 5.00M | 19,500,000 | — | ↗ |
| 2020-01-24 | BASKETT FOREST | 10% Owner | P-Purchase | A | Ordinary Shares with a nominal value of 0.001 GBP per share | 7,500,000 | 0.67 | 5.00M | 19,500,000 | — | ↗ |
| 2020-01-16 | TAYTON-MARTIN HELEN KATRINA | Officer | A-Award | A | Option to purchase Ordinary Shares | 280,896 | 0.00 | 365.16 | 280,896 | — | ↗ |
| 2020-01-16 | Rawcliffe Adrian | Director / Officer | A-Award | A | Option to purchase Ordinary Shares | 2,515,536 | 0.74 | 1.86M | 2,515,536 | — | ↗ |
| 2020-01-16 | Norry Elliot | Officer | A-Award | A | Option to purchase Ordinary Shares | 135,600 | 0.00 | 176.28 | 135,600 | — | ↗ |
| 2020-01-16 | Lunger John | Officer | A-Award | A | Option to purchase Ordinary Shares | 1,257,744 | 0.74 | 930.7K | 1,257,744 | — | ↗ |
| 2020-01-16 | Bertrand William C JR | Officer | A-Award | A | Option to purchase Ordinary Shares | 280,896 | 0.00 | 365.16 | 280,896 | — | ↗ |
| 2020-01-14 | Rawcliffe Adrian | Director / Officer | S-Sale | D | American Depositary Shares representing Ordinary Shares | 3,236 | 5.13 | 16.6K | 3,166 | — | ↗ |
Executive team
Top executives
EBIT / Employee
-126.3K
Shares Outstanding
265.05M
Executive compensation
Executive compensation (annual)
| # | Year | Executive | Salary | Bonus | Stock award | Option award | Incentive | Other | Total | % Stock- based |
Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2024 | Adrian Rawcliffe Chief Executive Officer | 676.0K | — | — | 1.07M | 324.5K | 42.8K | 2.11M | 50.53% | ↗ |
| 2 | 2024 | Cintia Piccina Chief Commercial Officer | 363.3K | — | — | 1.24M | 131.1K | 16.2K | 1.75M | 70.77% | ↗ |
| 3 | 2024 | William Bertrand Chief Operating Officer | 486.9K | — | — | 355.3K | 175.3K | 40.9K | 1.06M | 33.57% | ↗ |
| 4 | 2023 | Adrian Rawcliffe Chief Executive Officer | 650.0K | — | — | 1.72M | 370.5K | 37.4K | 2.77M | 61.87% | ↗ |
| 5 | 2023 | William Bertrand Chief Operating Officer | 468.2K | — | — | 507.8K | 200.1K | 39.0K | 1.22M | 41.79% | ↗ |
| 6 | 2023 | Helen Tayton-Martin Chief Business & Strategy Officer | 449.0K | — | — | 506.0K | 191.9K | 36.5K | 1.18M | 42.76% | ↗ |
| 7 | 2023 | Elliot Norry Chief Medical Officer | 446.4K | — | — | 504.8K | 190.8K | 39.0K | 1.18M | 42.74% | ↗ |
| 8 | 2023 | Gavin Wood Chief Financial Officer | 441.4K | — | — | 504.9K | 188.7K | 36.2K | 1.17M | 43.11% | ↗ |
| 9 | 2023 | Cintia Piccina Chief Commercial Officer | 74.2K | 50.0K | — | 501.0K | — | 367.1K | 992.3K | 50.49% | ↗ |
| 10 | 2022 | Adrian Rawcliffe Chief Executive Officer | 650.0K | — | — | 2.71M | — | 43.6K | 3.41M | 79.65% | ↗ |
| 11 | 2022 | Cintia Piccina Chief Commmercial Officer | 407.9K | 100.0K | — | 1.59M | 55.1K | 34.5K | 2.19M | 72.66% | ↗ |
| 12 | 2022 | Elliot Norry Chief Medical Officer | 446.4K | — | — | 1.22M | 60.3K | 42.4K | 1.77M | 68.99% | ↗ |
| 13 | 2022 | William Bertrand Chief Operating Officer | 468.2K | — | — | 814.5K | 63.2K | 42.4K | 1.39M | 58.67% | ↗ |
| 14 | 2022 | Helen Tayton-Martin Chief Business & Strategy Officer | 449.0K | — | — | 814.5K | 60.6K | 36.2K | 1.36M | 59.87% | ↗ |
| 15 | 2022 | Gavin Wood Chief Financial Officer | 441.4K | — | — | 814.5K | 59.6K | 33.6K | 1.35M | 60.37% | ↗ |
| 16 | 2021 | Adrian Rawcliffe Chief Executive Officer | 617.1K | — | — | 3.21M | 351.7K | 38.9K | 4.22M | 76.09% | ↗ |
| 17 | 2021 | Helen Tayton-Martin Chief Business Officer | 464.4K | — | — | 1.07M | 198.5K | 46.9K | 1.78M | 60.10% | ↗ |
| 18 | 2021 | William Bertrand Chief Operating Officer | 456.8K | — | — | 1.07M | 195.3K | 35.1K | 1.76M | 60.88% | ↗ |
| 19 | 2021 | Helen Tayton-Martin Chief Business & Strategy Officer | 438.1K | — | — | 1.07M | 187.3K | 44.2K | 1.74M | 61.49% | ↗ |
| 20 | 2021 | Gavin Wood Chief Financial Officer | 430.6K | — | — | 1.07M | 184.1K | 33.2K | 1.72M | 62.26% | ↗ |
| 21 | 2021 | John Lunger Chief Operating Officer | 430.0K | — | — | 1.07M | 183.8K | 32.1K | 1.72M | 62.34% | ↗ |
| 22 | 2021 | Elliot Norry Chief Medical Officer | 425.1K | — | — | 1.07M | 181.7K | 35.1K | 1.71M | 62.48% | ↗ |
| 23 | 2020 | Adrian Rawcliffe Chief Executive Officer | 574.0K | — | — | 1.72M | 378.8K | 33.4K | 2.70M | 63.49% | ↗ |
| 24 | 2020 | Helen Tayton-Martin Chief Business Officer | 450.9K | — | — | 857.7K | 223.2K | 23.3K | 1.56M | 55.15% | ↗ |
| 25 | 2020 | William Bertrand Chief Operating Officer | 443.5K | — | — | 857.7K | 219.5K | 30.5K | 1.55M | 55.29% | ↗ |
| 26 | 2020 | Gavin Wood Chief Financial Officer | 299.5K | 42.4K | — | 990.3K | 148.3K | 23.2K | 1.50M | 65.86% | ↗ |
| 27 | 2020 | John Lunger Chief Operating Officer | 400.0K | — | — | 857.7K | 198.0K | 31.8K | 1.49M | 57.66% | ↗ |
| 28 | 2020 | Elliot Norry Chief Medical Officer | 390.0K | 117.0K | — | 204.9K | 160.1K | 33.7K | 905.7K | 22.62% | ↗ |
| 29 | 2020 | Michael Garone Interim Chief Financial Officer | 217.0K | — | — | — | — | — | 217.0K | 0.00% | ↗ |
| 30 | 2019 | James Noble Former Chief Executive Officer | 606.5K | — | — | 1.92M | 254.7K | 8.00 | 2.82M | 67.94% | ↗ |
| 31 | 2019 | Adrian Rawcliffe Chief Executive Officer | 500.5K | — | — | 1.43M | 177.3K | 49.9K | 2.16M | 66.24% | ↗ |
| 32 | 2019 | William Bertrand Chief Operating Officer | 432.6K | — | — | 766.9K | 136.3K | 35.4K | 1.37M | 55.93% | ↗ |
| 33 | 2019 | Helen Tayton-Martin Chief Business Officer | 432.1K | — | — | 766.9K | 136.1K | 30.2K | 1.37M | 56.17% | ↗ |
| 34 | 2019 | John Lunger Chief Operating Officer | 366.9K | — | — | 435.5K | 94.5K | 35.7K | 932.6K | 46.70% | ↗ |
| 35 | 2019 | Michael Garone Interim Chief Financial Officer | 206.5K | — | — | — | — | — | 206.5K | 0.00% | ↗ |
| 36 | 2018 | James Noble Former Chief Executive Officer | 557.3K | — | — | 1.83M | 260.5K | 9.00 | 2.67M | 68.33% | ↗ |
| 37 | 2018 | James Noble Chief Executive Officer | 536.0K | — | — | 1.83M | 250.6K | 28.0K | 2.64M | 69.16% | ↗ |
| 38 | 2018 | Rafael Amado President, Research & Development | 468.0K | — | — | 1.89M | 198.9K | 43.3K | 2.60M | 72.70% | ↗ |
| 39 | 2018 | Adrian Rawcliffe Chief Executive Officer | 457.0K | — | — | 730.8K | 174.8K | 54.8K | 1.42M | 51.56% | ↗ |
| 40 | 2018 | Adrian Rawcliffe Chief Financial Officer | 457.0K | — | — | 730.8K | 174.8K | 46.8K | 1.41M | 51.85% | ↗ |
| 41 | 2018 | Helen Tayton-Martin Chief Business Officer | 408.3K | — | — | 730.8K | 156.2K | 22.0K | 1.32M | 55.48% | ↗ |
| 42 | 2018 | William Bertrand Chief Operating Officer | 416.0K | — | — | 685.1K | 159.1K | 35.1K | 1.30M | 52.89% | ↗ |
| 43 | 2018 | John Lunger Chief Operating Officer | 317.0K | — | — | 602.9K | 92.9K | 3.5K | 1.05M | 57.54% | ↗ |
| 44 | 2017 | William Bertrand Chief Operating Officer | 316.7K | — | — | 1.52M | 128.3K | 34.2K | 2.00M | 76.00% | ↗ |
| 45 | 2017 | James Noble Chief Executive Officer | 520.4K | — | — | 849.9K | 234.2K | 27.1K | 1.63M | 52.09% | ↗ |
| 46 | 2017 | Adrian Rawcliffe Chief Financial Officer | 443.7K | — | — | 849.9K | 199.7K | 42.6K | 1.54M | 55.34% | ↗ |
| 47 | 2017 | Rafael Amado Chief Medical Officer | 442.9K | — | — | 849.9K | 199.3K | 43.0K | 1.54M | 55.36% | ↗ |
| 48 | 2017 | Rafael Amado President, Research & Development | 442.9K | — | — | 849.9K | 199.3K | 43.0K | 1.54M | 55.36% | ↗ |
| 49 | 2017 | Helen Tayton-Martin Chief Business Officer | 364.3K | — | — | 849.9K | 163.9K | 19.5K | 1.40M | 60.81% | ↗ |
| 50 | 2016 | James Noble Chief Executive Officer | 401.9K | — | — | 1.41M | 100.5K | 21.2K | 1.94M | 72.94% | ↗ |
| 51 | 2016 | Adrian Rawcliffe Chief Financial Officer | 435.0K | — | — | 674.1K | 117.5K | 34.3K | 1.26M | 53.47% | ↗ |
| 52 | 2016 | Rafael Amado President, Research & Development | 430.0K | — | — | 674.1K | 116.1K | 20.3K | 1.24M | 54.34% | ↗ |
| 53 | 2016 | Rafael Amado Chief Medical Officer | 430.0K | — | — | 674.1K | 116.1K | 20.3K | 1.24M | 54.34% | ↗ |
| 54 | 2016 | Helen Tayton-Martin Chief Business Officer | 299.9K | — | — | 674.1K | 81.0K | 16.4K | 1.07M | 62.92% | ↗ |
| 55 | 2015 | Adrian Rawcliffe Chief Financial Officer | 336.5K | — | — | 2.38M | 151.4K | 42.4K | 2.91M | 81.78% | ↗ |
| 56 | 2015 | Rafael Amado Chief Medical Officer | 331.4K | — | — | 2.38M | 149.1K | 31.9K | 2.89M | 82.28% | ↗ |
| 57 | 2015 | James Noble Chief Executive Officer | 442.1K | — | — | — | 294.7K | 24.6K | 761.4K | 0.00% | ↗ |
CEO compensation breakdown
Proxy statements
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Helen Katrina Tayton-Martin | Co-Founder | 677.4K | — |
| Christopher James Hill | CEO, CFO, Secretary & Director | — | male |
| Dana Lynch | Senior Director of Corporate Communications | — | female |
| Juli Miller | Vice President of Corporate Affairs & Investor Relations | — | — |
| Kimberly Freeman | Vice President of Commercial Planning | — | female |
| Laura Gunn | Vice President of Medical Affairs | — | — |
ESG Score History
No data available for this company.
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for ADAPY
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
